AMBROBENE
30MG TBL NOB 20
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 18.02.2022 | |||
Interruption of marketing | 07.02.2022 |
0202900 |
Commercial/marketing reasons | 28.2.2022 |
Resumption of marketing | 25.03.2020 | |||
Interruption of marketing | 05.03.2020 |
0202900, 0223157, 0043950 |
Capacity/distribution reasons | 04/2020 |
Placing on the market | 04.10.2010 |
All reports are available in the Overview.